These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 24374193)
1. Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals. Moy RH; Gold B; Molleston JM; Schad V; Yanger K; Salzano MV; Yagi Y; Fitzgerald KA; Stanger BZ; Soldan SS; Cherry S Immunity; 2014 Jan; 40(1):51-65. PubMed ID: 24374193 [TBL] [Abstract][Full Text] [Related]
2. Rift Valley Fever Virus Nucleoprotein Triggers Autophagy to Dampen Antiviral Innate Immune Responses. Zhu X; Guan Z; Fang Y; Zhang Y; Guan Z; Li S; Peng K J Virol; 2023 Apr; 97(4):e0181422. PubMed ID: 36939341 [TBL] [Abstract][Full Text] [Related]
3. Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations. Xu L; Paine AC; Barbeau DJ; Alencastro F; Duncan AW; McElroy AK J Virol; 2023 Sep; 97(9):e0085323. PubMed ID: 37695055 [TBL] [Abstract][Full Text] [Related]
4. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice. Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372 [TBL] [Abstract][Full Text] [Related]
5. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates. Terasaki K; Tercero BR; Makino S Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573 [TBL] [Abstract][Full Text] [Related]
6. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952 [TBL] [Abstract][Full Text] [Related]
7. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus]. Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371 [TBL] [Abstract][Full Text] [Related]
8. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection. López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044 [TBL] [Abstract][Full Text] [Related]
9. Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses. Dodd KA; McElroy AK; Jones ME; Nichol ST; Spiropoulou CF J Virol; 2013 Jun; 87(11):6161-71. PubMed ID: 23536675 [TBL] [Abstract][Full Text] [Related]
10. Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway. Brahms A; Mudhasani R; Pinkham C; Kota K; Nasar F; Zamani R; Bavari S; Kehn-Hall K J Virol; 2017 Nov; 91(21):. PubMed ID: 28794043 [TBL] [Abstract][Full Text] [Related]
11. Identification and evaluation of antivirals for Rift Valley fever virus. Lang Y; Li Y; Jasperson D; Henningson J; Lee J; Ma J; Li Y; Duff M; Liu H; Bai D; McVey S; Richt JA; Ikegami T; Wilson WC; Ma W Vet Microbiol; 2019 Mar; 230():110-116. PubMed ID: 30827375 [TBL] [Abstract][Full Text] [Related]
12. Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters. Westover JB; Mathis A; Taylor R; Wandersee L; Bailey KW; Sefing EJ; Hickerson BT; Jung KH; Sheridan WP; Gowen BB Antiviral Res; 2018 Aug; 156():38-45. PubMed ID: 29864447 [TBL] [Abstract][Full Text] [Related]
13. A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection. Harmon B; Bird SW; Schudel BR; Hatch AV; Rasley A; Negrete OA J Virol; 2016 Aug; 90(16):7084-7097. PubMed ID: 27226375 [TBL] [Abstract][Full Text] [Related]
14. Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus? Beechler BR; Bengis R; Swanepoel R; Paweska JT; Kemp A; van Vuren PJ; Joubert J; Ezenwa VO; Jolles AE Transbound Emerg Dis; 2015 Feb; 62(1):24-32. PubMed ID: 24330522 [TBL] [Abstract][Full Text] [Related]
16. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion. Bamia A; Marcato V; Boissière M; Mansuroglu Z; Tamietti C; Romani M; Simon D; Tian G; Niedergang F; Panthier JJ; Flamand M; Souès S; Bonnefoy E J Virol; 2020 Dec; 95(1):. PubMed ID: 33087469 [TBL] [Abstract][Full Text] [Related]
17. MAVS mediates a protective immune response in the brain to Rift Valley fever virus. Hum NR; Bourguet FA; Sebastian A; Lam D; Phillips AM; Sanchez KR; Rasley A; Loots GG; Weilhammer DR PLoS Pathog; 2022 May; 18(5):e1010231. PubMed ID: 35584192 [TBL] [Abstract][Full Text] [Related]
18. Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development. Reed C; Lin K; Wilhelmsen C; Friedrich B; Nalca A; Keeney A; Donnelly G; Shamblin J; Hensley LE; Olinger G; Smith DR PLoS Negl Trop Dis; 2013; 7(4):e2156. PubMed ID: 23593523 [TBL] [Abstract][Full Text] [Related]
19. Rift Valley fever virus infection in golden Syrian hamsters. Scharton D; Van Wettere AJ; Bailey KW; Vest Z; Westover JB; Siddharthan V; Gowen BB PLoS One; 2015; 10(1):e0116722. PubMed ID: 25607955 [TBL] [Abstract][Full Text] [Related]